SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

SVB Leerink Maintains Outperform on Myovant Sciences, Lowers Price Target to $27

SVB Leerink maintains Myovant Sciences (NYSE:MYOV) with a Outperform and lowers the price target from $28 to $27.

Benzinga · 05/19/2020 10:41

SVB Leerink maintains Myovant Sciences (NYSE:MYOV) with a Outperform and lowers the price target from $28 to $27.